Raphael Pharmaceutical (RAPH) Operating Income Growth (3y) (2023 - 2024)

Raphael Pharmaceutical (RAPH) Operating Income Growth (3y) (2023 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Op. Inc Growth (3y) (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	29.31%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	4.24%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.90%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	1.82%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-74.25%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	27.21%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	35.42%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Raphael Pharmaceutical	28.25 Mn	28.25 Mn	-	21.98%

Download Data